LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors

International Journal of Gynecological Cancer

Volumn 22, Issue 1, 2012, Pages 54-62

  Yin, Mingzhu ^a   Lou, Chun ^a   Zhang, Wang ^a   Meng, Fanling ^a   Zhang, Haiyu ^a   Ning, Xiaoming ^a   Zhou, Rouli ^b   Dong, Xinshu ^a   Lou, Ge ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Immunohistochemistry; LAPTM4B; Metastatic ovarian tumor; Survival

Indexed keywords

LYSOSOME ASSOCIATED PROTEIN TRANSMEMBRANE 4BETA; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MEMBRANE PROTEINS; MIDDLE AGED; ONCOGENE PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84863273287     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318234f9ac     Document Type: Article

References (31)

1. Yada-Hashimoto N, Yamamoto T, Kamiura S, et al. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol. 2003;89:314-317. (Pubitemid 36457882)
2. Parker RT, Currie JL. Metastatic tumors of ovary. In: Coppleson M, ed. Gynecologic Oncology. 2nd ed. New York, NY: Churchill Livingstone; 1992:987-999.
3. Young RH, Scully RE. Metastatic tumors of the ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York, NY: Springer; 2002:1063-1101.
4. Lee SJ, Bae JH, Lee AW, et al. Clinical characteristics of metastatic tumors to the ovaries. J Korean Med Sci. 2009;24:114-119.
5. Ulbright T, Roth L, Stehman F. Secondary ovarian neoplasia: a clinicopathologic study of 35 cases. Cancer. 1984;53:1164-1174. (Pubitemid 14196498)
6. Petru E, Pickel H, Heydarfadai M, et al. Nongenital cancers metastatic to the ovary. Gynecol Oncol. 1992;44:83-86.
7. Perucchini D, Caduff R, Schar G, et al. Ovarian metastasis of extragenital tumors at the Zurich University Gynecologic Clinic 1978-1990 [in German]. Geburtshilfe Frauenheilkd. 1996;56:351-356. (Pubitemid 26259432)
8. Kikkawa F, Ino K, Nomura S, et al. Prognostic factors of secondary ovarian carcinoma. Oncology. 2002;63:124-129.
9. Moore R, Chung M, Cornelius G, et al. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol. 2004;93:87-91. (Pubitemid 38429553)
10. Kim HK, Heo DS, Bang YJ, et al. Prognostic factors of Krukenberg's tumor. Gynecol Oncol. 2001;82:105-109. (Pubitemid 32634961)
11. Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract. Analysis of 325 cases. Cancer. 1984;53:1978-1984. (Pubitemid 14127658)
12. Webb MJ, Decker DG, Mussey E. Cancer metastatic to the ovary: factors influencing survival. Obstet Gynecol. 1975;45:391-396.
13. Al-Agha OM, Nicastri AD. An in-depth look at Krukenberg tumor: an overview. Arch Pathol Lab Med. 2006;130:1725-1730. (Pubitemid 44683806)
14. Kobayashi O, Sugiyama Y, Cho H, et al. Clinical and pathological study of gastric cancer with ovarian metastasis. Int J Clin Oncol. 2003;8:67-71. (Pubitemid 36548473)
15. Liu XR, Zhou RL, Zhang QY, et al. Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma. World J Gastroenterol. 2004;10:1555-1559.
16. Shao GZ, Zhou RL, Zhang QY, et al. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Oncogene. 2003;22:5060-5069.
17. Liu Y, Zhang QY, Qian N, et al. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer. Ann Oncol. 2007;18:311-316. (Pubitemid 46323099)
18. Kasper G, Vogel A, Klaman I, et al. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Cancer Lett. 2005;224:93-103. (Pubitemid 40720370)
19. Peng C, Zhou RL, Shao GZ, et al. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. World J Gastroenterol. 2005;11:2704-2708. (Pubitemid 40704233)
20. He J, Shao G, Zhou R. Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells [in Chinese]. Beijing Da Xue Xue Bao. 2003;35:348-352.
21. Yang H, Xiong F, Wei X, et al. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo. Cancer Lett. 2010;294:236-244.
22. Zhou L, He XD, Chen J, et al. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma. Eur J Cancer. 2007;43:809-815. (Pubitemid 46502911)
23. Meng FL, Yin MZ, Song HT, et al. LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma. Int J Gynecol Cancer. 2010;20:745-750.
24. Yang H, Xiong FX, Lin M, et al. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2010;136:275-281.
25. Yin M, Li C, Li X, et al. Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer. J Surg Oncol. 2011;104:29-36.
26. Tan KL, Tan WS, Lim JF, et al. Krukenberg tumors of colorectal origin: a dismal outcome - experience of a tertiary center. Int J Colorectal Dis. 2010;25:233-238.
27. Cheong JH, Hyung WJ, Chen J, et al. Surgical management and outcome of metachronous Krukenberg tumors from gastric cancer. Journal of Surg Oncol. 2004;87:39-45. (Pubitemid 38880278)
28. Baker VV, Borst MP, Dixon D, et al. c-myc amplification in ovarian cancer. Gynecol Oncol. 1990;38:340-342. (Pubitemid 20362552)
29. Müller-Tidow C, Diederichs S, Schrader MG, et al. Cyclin A1 is highly expressed in aggressive testicular germ cell tumors. Cancer Lett. 2003;190:89-95. (Pubitemid 36106559)
30. Yauch RL, Hemler ME. Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem J. 2000;351:629-637.
31. Yin M, Xu Y, Lou G, et al. LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis. Int J Cancer. 2011;129:629-635.